Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Patient-derived induced pluripotent stem cells as an in vitro model for arrhythmogenic right ventricular cardiomyopathy.
EF 2021-22
Résumé
The heart consists of four chambers, two atria and two ventricles, whose contractions must be coordinated for the efficient pumping of blood to the entire body. If this coordination is affected, it could lead to sudden cardiac death. Specifically, arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disease that results in a disrupted contraction of the ventricles that can be fatal. ARVC affects 1 in 5000 people, including the elderly and young people- even athletes. One of the genetic mutations that causes ARVC is in a gene called TMEM43, which was first found in Newfoundland, Canada. The current treatment involves the implantation of a defibrillator that generates electric shocks to set the heart back into a regular rhythm, which is lifesaving but painful and strongly impacts quality of life.
Currently, we do not have any suitable models to study human ARVC in the lab. My project aims to create a model that mimics this disease outside the body. This model will allow me to discover how the genetic mutation causes ARVC and to identify druggable targets that will enable the development of effective and painless treatments in the future.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
458349
Name
Chang Matthew Lok-Man
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Patient-derived induced pluripotent stem cells as an in vitro model for arrhythmogenic right ventricular cardiomyopathy.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Arrhythmogenic Right Ventricular Cardiomyopathy; Cardiology; Drug Screening; Genetics/Genetic Diseases; Ipsc Disease Modelling; Patch-Clamp Technique; Single-Cell Rna Sequencing
Abstract
The heart consists of four chambers, two atria and two ventricles, whose contractions must be coordinated for the efficient pumping of blood to the entire body. If this coordination is affected, it could lead to sudden cardiac death. Specifically, arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disease that results in a disrupted contraction of the ventricles that can be fatal. ARVC affects 1 in 5000 people, including the elderly and young people- even athletes. One of the genetic mutations that causes ARVC is in a gene called TMEM43, which was first found in Newfoundland, Canada. The current treatment involves the implantation of a defibrillator that generates electric shocks to set the heart back into a regular rhythm, which is lifesaving but painful and strongly impacts quality of life.
Currently, we do not have any suitable models to study human ARVC in the lab. My project aims to create a model that mimics this disease outside the body. This model will allow me to discover how the genetic mutation causes ARVC and to identify druggable targets that will enable the development of effective and painless treatments in the future.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chang, Matthew Lok-Man
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~